In this expert panel discussion, speakers Weiss, Kelly, and Lipset reflect on the FDA’s recent AI guidance and ponder its influence on patient-centric DCTs. They examine lessons from DCT adoption, stressing the importance of global harmonization and the ethical use of AI. A deep dive into challenges and prospects, this webinar forecasts the transformative impact of AI on data integrity and patient safety within the DCT ecosystem.
Learn more at www.pcmtrials.com
